Interim Results Of Betibeglogene Autotemcel Gene Therapy In Pediatric Patients With Transfusion-Dependent B-Thalassemia (Tdt) Treated In The Phase 3 Northstar-2 (Hgb-207) And Northstar-3 (Hgb-212) Studies

BONE MARROW TRANSPLANTATION(2021)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要